Medications for type 2 diabetes and weight loss poorly prescribed
Three independent, preliminary research studies have found that new type 2 diabetes and weight-loss medications are often not prescribed...
top of page
Browse by category
Search
GLP-1s do not increase aspiration or pneumonia in surgery patients
There is no association between prescription glucagon-like peptide-1 (GLP-1) agonist medications and increased risk of aspiration or...
Journal Watch 20/3/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Entera Bio reveals data for oral GLP-2 peptide for short bowel syndrome patients
Entera Bio has revealed positive pharmacokinetic results from its collaborative research combining a proprietary long acting GLP-2...
Nasal spray may reduce severity of sleep apnoea
Australian researchers have discovered that a bedtime nasal spray has the potential to reduce the severity of obstructive sleep apnoea...
Middle-age obesity may be caused by changes in the shapes of neurons in the brain, impacting the role of MC4Rs
Middle-age obesity is caused by age-related changes in the shape of neurons in the hypothalamus, a region of the brain that controls...
Metabolic surgery results in cardiometabolic improvements in people with severe obesity
Patients who underwent metabolic surgery had significant improvements in cardiometabolic health, according to researchers from Vanderbilt...
Innovative program connects bariatric surgery and kidney transplant access for patients who have obesity and end-stage renal disease
A collaborative study between bariatric and transplant teams has created a viable pathway for patients with obesity who also have...
Journal Watch 13/3/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Fractyl’s Rejuva platform demonstrates potent and durable effects of a single dose of a human GLP-1 pancreatic gene therapy transgene vs semaglutide for diabetes and obesity
Fractyl Health has revealed promising new preclinical findings for the first clinical candidate in its Rejuva pancreatic gene therapy...
Browse by tag
bottom of page